 Predictive Value of Tests
"Predictive Value of Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
| Descriptor ID |
D011237
|
| MeSH Number(s) |
E05.318.780.800.650 N05.715.360.780.700.640 N06.850.520.445.800.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Predictive Value of Tests".
Below are MeSH descriptors whose meaning is more specific than "Predictive Value of Tests".
This graph shows the total number of publications written about "Predictive Value of Tests" by people in this website by year, and whether "Predictive Value of Tests" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1987 | 0 | 2 | 2 | | 1988 | 0 | 5 | 5 | | 1989 | 0 | 2 | 2 | | 1990 | 0 | 3 | 3 | | 1991 | 0 | 12 | 12 | | 1992 | 0 | 7 | 7 | | 1993 | 0 | 8 | 8 | | 1994 | 0 | 13 | 13 | | 1995 | 0 | 10 | 10 | | 1996 | 0 | 11 | 11 | | 1997 | 0 | 10 | 10 | | 1998 | 0 | 13 | 13 | | 1999 | 0 | 16 | 16 | | 2000 | 0 | 17 | 17 | | 2001 | 0 | 18 | 18 | | 2002 | 0 | 26 | 26 | | 2003 | 0 | 32 | 32 | | 2004 | 0 | 23 | 23 | | 2005 | 0 | 35 | 35 | | 2006 | 0 | 36 | 36 | | 2007 | 0 | 46 | 46 | | 2008 | 2 | 54 | 56 | | 2009 | 1 | 59 | 60 | | 2010 | 0 | 64 | 64 | | 2011 | 0 | 71 | 71 | | 2012 | 0 | 60 | 60 | | 2013 | 0 | 64 | 64 | | 2014 | 0 | 52 | 52 | | 2015 | 0 | 67 | 67 | | 2016 | 0 | 137 | 137 | | 2017 | 0 | 57 | 57 | | 2018 | 2 | 53 | 55 | | 2019 | 1 | 65 | 66 | | 2020 | 1 | 38 | 39 | | 2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Predictive Value of Tests" by people in Profiles.
-
Cai L, Chen Y, Xiao SY. Clinicopathologic Features of Chronic Intestinal Schistosomiasis and Its Distinction From Crohn Disease. Am J Surg Pathol. 2021 03 01; 45(3):430-438.
-
Chen HI, Lapadat R, Lastra RR, Biernacka A, Reeves W, Mueller J, Pambuccian SE, Barkan GA, Wojcik EM, Antic T. Accuracy of Subclassification and Grading of Renal Tumors on Fine Needle Aspiration Cytology Alone. Acta Cytol. 2021; 65(2):140-149.
-
Yamashita R, Long J, Longacre T, Peng L, Berry G, Martin B, Higgins J, Rubin DL, Shen J. Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study. Lancet Oncol. 2021 01; 22(1):132-141.
-
Menacho ST, Grandhi R, Delic A, Anadani M, Ziai WC, Awad IA, Hanley DF, de Havenon A. Impact of Intracranial Pressure Monitor-Guided Therapy on Neurologic Outcome After Spontaneous Nontraumatic Intracranial Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105540.
-
Aouad P, Koktzoglou I, Milani B, Serhal A, Nazari J, Edelman RR. Radial-based acquisition strategies for pre-procedural non-contrast cardiovascular magnetic resonance angiography of the pulmonary veins. J Cardiovasc Magn Reson. 2020 11 30; 22(1):78.
-
Singh N, Anchan RK, Besser SA, Belkin MN, Cruz MD, Lee L, Yu D, Mehta N, Nguyen AB, Alenghat FJ. High sensitivity Troponin-T for prediction of adverse events in patients with COVID-19. Biomarkers. 2020 Dec; 25(8):626-633.
-
Schoots IG, Barentsz JO, Bittencourt LK, Haider MA, Macura KJ, Margolis DJA, Moore CM, Oto A, Panebianco V, Siddiqui MM, Tempany C, Turkbey B, Villeirs GM, Weinreb JC, Padhani AR. PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative Review. AJR Am J Roentgenol. 2021 01; 216(1):3-19.
-
Redman MW, Papadimitrakopoulou VA, Minichiello K, Hirsch FR, Mack PC, Schwartz LH, Vokes E, Ramalingam S, Leighl N, Bradley J, Miao J, Moon J, Highleyman L, Miwa C, LeBlanc ML, Malik S, Miller VA, Sigal EV, Adam S, Wholley D, Sigman C, Smolich B, Blanke CD, Kelly K, Gandara DR, Herbst RS. Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol. Lancet Oncol. 2020 12; 21(12):1589-1601.
-
Zhou D, Jiang Y, Zhong X, Cox NJ, Liu C, Gamazon ER. A unified framework for joint-tissue transcriptome-wide association and Mendelian randomization analysis. Nat Genet. 2020 11; 52(11):1239-1246.
-
Zhao L, Xu L, Hemmerich A, Ferguson NL, Guy CD, McCall SJ, Cardona DM, Westerhoff M, Pai RK, Xiao SY, Liu B, Green CL, Hart J, Zhang X. Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility. Virchows Arch. 2021 Mar; 478(3):427-434.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|